Webcasts

Wednesday, October 6, 2021 at 12pm EDT | 9am PDT | 5pm BST | 6pm CEST
In this webinar, you will learn about the possibility of GMP method transfer for HCP assays leveraging a robust and automated workflow based on combining data-dependent and data-independent mass spectrometry. A study of data from multiple projects over three years demonstrated the robustness and reproducibility of the method.

Moving SWATH LC–MS Host Cell Protein Analysis into a GMP Environment?

Friday, June 11, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Improving Sensitivity of LC-MS Methods for Characterization and Quantitation of Synthetic Oligonucleotides 

***Live: Monday, May 24, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** Join us to learn best practices in method development for intact and subunit purity analysis for mAbs by reversed-phase liquid chromatography (RPLC), including how to best adjust method parameters such as temperature, gradient slope, and flow rate to obtain high-quality impurity profiling and ensure method robustness and reproducibility.  ***On Demand until May 24, 2022***

Method Development Strategies for Purity Analysis of Proteins by Intact and Subunit Analysis

***Live: Monday, April 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST ***  Analytical characterization of biomolecules can be challenging because impurities from the synthesis, expression, and degradation of the intended product make the samples complex. Discover the latest innovations, using high-throughput mass spectrometry, to streamline workflows, and simplify complicated analysis, increase throughput, and accelerate bringing biomolecules to market.***On Demand until Apr. 26, 2022***

Ultra-fast Analysis of Intact Proteins and Oligonucleotides Using High-Throughput Mass Spectrometry 

***Available Now!***  In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until March 30, 2022*

Profiling the HLA-II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Using Mass Spectrometry. 

***Live: Wednesday March 17, 2021 at 11am EDT| 8am PDT| 4pm GMT| 5pm CET ***  Single-use material selection is a crucial element of process development for bioprocessing, and emerging viral vector-based therapies have special requirements.  Learn about efforts to better understand the relationship of single-use material selection and process impact to improve yield. ***On Demand until March 17, 2022***

A Material Characterization Study for AAV Process Development and Tool Selection 

***Live: Wednesday, March 3, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET ***  In this presentation we will demonstrate the gains in proteome characterization that can be achieved by using modern HPLC materials, both core–shell and full porous based. We will also show improvements that can be realized via selectivity optimization of not only the HPLC column chemistry but also trap chemistries when using a trap-and-elute workflow. .***On Demand until Mar. 3, 2022***

Improving the Power of Nano LC–MS Workflows in Bottom-Up Proteomics with Core-Shell Based Nano Columns and Expanded Selectivities

***Live: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET***  Join global industry and regulatory experts as they discuss current E&L hot topics related to pharmaceuticals, biopharmaceuticals and medical devices. ***On demand available after final airing until Feb. 24, 2022***

The Ever-Changing World of Extractables and Leachables, Part 2 A Free Virtual Conference 

***Live: Wednesday, January 20, 2021 at 11am EST | 8am PST | 4 pm GMT | 5pm CET *** Cell culture media (CCM) optimization is a critical step during the development and scale up of biotherapeutic manufacturing process. In particular, the emphasis on quality by design has made it necessary to understand how the components of CCM change during production and how these changes relate to product quality. In this webcast, learn how targeted cell-culture media workflow can help scientists understand growth media for biotherapeutics and improve their manufacturing process. ***On demand available after final airing until Jan. 20, 2022***

Webcasts: Biopharmaceutical Analysis